Regulations/Legal

Latest Issue of OR Manager
December 2021
Home Regulations/Legal

The Joint Commission posts new sentinel event data

Editor's Note The Joint Commission, on September 29, released new sentinel event data for the first 6 months of 2021. The summary data of sentinel event statistics for the first half of 2021 covers 16,695 incidents reported from 1995 through June 30, 2021. Of these sentinel events: 47% led to…

Read More

By: Judy Mathias
October 4, 2021
Share

CDC: Safety monitoring of COVID-19 vaccine booster dose

Editor's Note This study by researchers at the Centers for Disease Control and Prevention finds that adverse reactions after the third dose of Pfizer-BioNTech’s COVID-19 vaccine were similar to those after the second dose. Of 12,591 participants who completed a survey after all three doses: 79.4% and 74.1% reported local…

Read More

By: Judy Mathias
October 1, 2021
Share

ECRI partners with FDA on safety of materials in medical devices

Editor's Note ECRI, on September 30, announced a new partnership with the Food and Drug Administration (FDA) to improve the safety of medical devices through the use of safer materials. ECRI is developing safety reports for materials commonly used in implantable medical devices and assessing their possible effects on patients…

Read More

By: Judy Mathias
October 1, 2021
Share

Sponsored Message

Outdoor daylight exposure, longer sleep promote wellbeing during COVID-19 restrictions

Editor's Note This study by Israeli researchers finds that restrictions implemented during COVID-19 dramatically altered daily routines and limited time spent outdoors, which resulted in deteriorating personal wellbeing. The analysis of 7,517 adults from 40 countries who were surveyed during the 2020 COVID-19 restrictions found that social restrictions impaired all…

Read More

By: Judy Mathias
September 23, 2021
Share

FDA authorizes Pfizer-BioNTech COVID-19 vaccine boosters for certain populations

Editor's Note The Food and Drug Administration (FDA) on September 22 amended the emergency use authorization (EUA) for Pfizer-BioNTech’s COVID-19 vaccine to allow for use of a single booster to be administered at least 6 months after completion of the primary series in those: 65 years of age and older…

Read More

By: Judy Mathias
September 23, 2021
Share

Effect of interruptions in Medicare patient treatment during COVID-19 on physicians, practices

Editor's Note This study from the University of Minnesota School of Public Health, Minneapolis, and Harvard Medical School, Boston, finds that practice interruptions in the treatment of Medicare patients spiked in April 2020, and interruption-without-return rates were larger for older physicians. In this analysis of 547,849 physicians billing Medicare: Practice…

Read More

By: Judy Mathias
September 21, 2021
Share

Sponsored Message

COVID-19 vaccination requirements result in HCW terminations, resignations

Editor's Note COVID-19 vaccination requirements have caused some organizations to fire healthcare workers (HCWs) for noncompliance, and HCWs have quit over the policies, the September 17 Becker’s Hospital Review reports. Healthcare systems announcing resignations and terminations include the following: Morehead, Kentucky-based St Claire HealthCare has fired 23 HCWs for noncompliance…

Read More

By: Judy Mathias
September 21, 2021
Share

FDA: Class I recall of Medtronic Pipeline Flex Embolization devices

Editor's Note The Food and Drug Administration (FDA), on September 20, identified Medtronic’s recall of its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology as Class I, the most serious. The devices, which are used to treat brain aneurysms, were recalled because there is a risk…

Read More

By: Judy Mathias
September 21, 2021
Share

CDC: COVID-19 vaccine efficacy for preventing hospitalization

Editor's Note In this study, Centers for Disease Control and Prevention (CDC) researchers report on the comparative effectiveness of COVID-19 vaccines against hospitalization of US adults without immunocompromised conditions. Included in the case-control analysis were 3,689 adults aged 18 years and older who were hospitalized at 21 US hospitals between…

Read More

By: Judy Mathias
September 20, 2021
Share

FDA committee votes against COVID-19 vaccine boosters for general population

Editor's Note The Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee on September 17 voted that there was not enough safety and effectiveness data to approve a third Pfizer COVID-19 vaccine dose for those 16 years and older. The committee did vote to recommend approval of…

Read More

By: Judy Mathias
September 20, 2021
Share

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
December 2021
Video Spotlight
Live chat by BoldChat